{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:36:38Z","timestamp":1792269398756,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.neuropharm.2021.108835","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T02:24:10Z","timestamp":1634005450000},"page":"108835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Delayed inhibition of ERK and p38 attenuates neuropathic pain without affecting motor function recovery after peripheral nerve injury"],"prefix":"10.1016","volume":"202","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5657-1844","authenticated-orcid":false,"given":"SaiSai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YingTing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenFeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhenYu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FeiFan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaYu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108835_bib1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1179\/174313209X380883","article-title":"Inhibition of MAPK ERK impairs axonal regeneration without an effect on neuronal loss after nerve injury","volume":"31","author":"Agthong","year":"2009","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2021.108835_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.117.014399","article-title":"Etiology and pharmacology of neuropathic pain","volume":"70","author":"Alles","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108835_bib3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/0022034516653604","article-title":"Microglial signaling in chronic pain with a special focus on caspase 6, p38 MAP kinase, and sex dependence","volume":"95","author":"Berta","year":"2016","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.neuropharm.2021.108835_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuron.2019.09.018","article-title":"The genetics of neuropathic pain from model organisms to clinical application","volume":"104","author":"Calvo","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108835_bib5","first-page":"321","article-title":"Changes of voltage-gated sodium channels in sensory nerve regeneration and neuropathic pain models","volume":"33","author":"Casals-Diaz","year":"2015","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli","year":"2019","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108835_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.expneurol.2014.09.006","article-title":"Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets","volume":"261","author":"Chan","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108835_bib8","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","article-title":"Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain","volume":"100","author":"Chen","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108835_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: an animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2021.108835_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184647","article-title":"P2X3 receptor involvement in endometriosis pain via ERK signaling pathway","volume":"12","author":"Ding","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2021.108835_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/micr.20685","article-title":"Functional assessment after sciatic nerve injury in a rat model","volume":"29","author":"Dinh","year":"2009","journal-title":"Microsurgery"},{"key":"10.1016\/j.neuropharm.2021.108835_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s13311-020-00905-7","article-title":"Central nervous system targets: glial cell mechanisms in chronic pain","volume":"17","author":"Donnelly","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2021.108835_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneumeth.2016.10.018","article-title":"Recovery of sensorimotor function following sciatic nerve injury across multiple rat strains","volume":"275","author":"Ganguly","year":"2017","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2021.108835_bib14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fphar.2018.01026","article-title":"17 beta-Estradiol enhances Schwann cell differentiation via the ERbeta-ERK1\/2 signaling pathway and promotes remyelination in injured sciatic nerves","volume":"9","author":"Gu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108835_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nn.4189","article-title":"Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain","volume":"19","author":"Guan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/ar.24126","article-title":"Promotion of peripheral nerve regeneration by stimulation of the extracellular signal-regulated kinase (ERK) pathway","volume":"302","author":"Hausott","year":"2019","journal-title":"Anat. Rec."},{"key":"10.1016\/j.neuropharm.2021.108835_bib17","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.sjbs.2017.11.027","article-title":"ERK\/MAPK and PI3K\/AKT signal channels simultaneously activated in nerve cell and axon after facial nerve injury","volume":"24","author":"Huang","year":"2017","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib18","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2017.01014","article-title":"Neuroinflammation, bone marrow stem cells, and chronic pain","volume":"8","author":"Huh","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2021.108835_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrn.2018.2","article-title":"Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential","volume":"19","author":"Inoue","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.2009.00801.x","article-title":"Animal models of neuropathic pain","volume":"25","author":"Jaggi","year":"2011","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108835_bib21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41583-019-0218-1","article-title":"Astrocytes in chronic pain and itch","volume":"20","author":"Ji","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"Ji","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2021.108835_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1744-8069-3-33","article-title":"p38 MAPK, microglial signaling, and neuropathic pain","volume":"3","author":"Ji","year":"2007","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2021.108835_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI81950","article-title":"CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5","volume":"126","author":"Jiang","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2021.108835_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrn.2016.162","article-title":"Structural plasticity and reorganisation in chronic pain","volume":"18","author":"Kuner","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5607\/en.2018.27.4.267","article-title":"Dexmedetomidine attenuates neuropathic pain by inhibiting P2X7R expression and ERK phosphorylation in rats","volume":"27","author":"Lin","year":"2018","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.neuropharm.2021.108835_bib27","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.2174\/0929867321666140915143040","article-title":"p38 MAPK: a potential target of chronic pain","volume":"21","author":"Lin","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108835_bib28","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1097\/j.pain.0000000000000366","article-title":"Wnt\/Ryk signaling contributes to neuropathic pain by regulating sensory neuron excitability and spinal synaptic plasticity in rats","volume":"156","author":"Liu","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2021.108835_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225586","article-title":"Upregulation of ERK phosphorylation in rat dorsal root ganglion neurons contributes to oxaliplatin-induced chronic neuropathic pain","volume":"14","author":"Maruta","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2021.108835_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jnr.23672","article-title":"Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway","volume":"94","author":"Ni","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2021.108835_bib31","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2004.01.007","article-title":"MAPK activation in nociceptive neurons and pain hypersensitivity","volume":"74","author":"Obata","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.aaf8933","article-title":"Neural circuits for pain: recent advances and current views","volume":"354","author":"Peirs","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108835_bib33","first-page":"8561704","article-title":"Peripheral nerve injury-induced astrocyte activation in spinal ventral horn contributes to nerve regeneration","author":"Qian","year":"2018","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2021.108835_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","article-title":"The role of PI3K\/akt and ERK in neurodegenerative disorders","volume":"35","author":"Rai","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2021.108835_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/WNR.0000000000000554","article-title":"Behavioral characterization of neuropathic pain on the glabrous skin areas reinnervated solely by axotomy-regenerative axons after adult rat sciatic nerve crush","volume":"27","author":"Ren","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2021.108835_bib36","first-page":"3412","article-title":"Spinal motor circuit synaptic plasticity after peripheral nerve injury depends on microglia activation and a CCR2 mechanism","volume":"39","author":"Rotterman","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib37","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2021.108835_bib38","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2217\/nnm-2018-0054","article-title":"p38 siRNA-encapsulated PLGA nanoparticles alleviate neuropathic pain behavior in rats by inhibiting microglia activation","volume":"13","author":"Shin","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.neuropharm.2021.108835_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbi.2017.11.011","article-title":"The role of P2X7R\/ERK signaling in dorsal root ganglia satellite glial cells in the development of chronic postsurgical pain induced by skin\/muscle incision and retraction (SMIR)","volume":"69","author":"Song","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108835_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/glia.23527","article-title":"Overexpression of P2X4 receptor in Schwann cells promotes motor and sensory functional recovery and remyelination via BDNF secretion after nerve injury","volume":"67","author":"Su","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108835_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2016.12.047","article-title":"Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK\/ERK pathway by targeting brain-derived neurotrophic factor","volume":"646","author":"Sun","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2021.108835_bib42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.neuropharm.2021.108835_bib43","first-page":"8685954","article-title":"Therapeutic approaches for peripheral and central neuropathic pain","author":"Szok","year":"2019","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108835_bib44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2015.10.006","article-title":"Spinal inhibition of p38 MAP kinase reduces inflammatory and neuropathic pain in male but not female mice: sex-dependent microglial signaling in the spinal cord","volume":"55","author":"Taves","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2021.108835_bib45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s10194-018-0836-4","article-title":"PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord","volume":"19","author":"Wang","year":"2018","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2021.108835_bib46","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108835_bib47","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1523\/JNEUROSCI.5812-11.2012","article-title":"p38 MAPK activation promotes denervated Schwann cell phenotype and functions as a negative regulator of Schwann cell differentiation and myelination","volume":"32","author":"Yang","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108835_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-016-0652-1","article-title":"Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5\/ERK pathway in the trigeminal ganglion of mice","volume":"13","author":"Zhang","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2021.108835_bib49","first-page":"9348037","article-title":"Inhibition of P38 MAPK downregulates the expression of IL-1beta to protect lung from acute injury in intestinal ischemia reperfusion rats","author":"Zheng","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2021.108835_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/1744806919858260","article-title":"Penehyclidine hydrochloride suppressed peripheral nerve injury-induced neuropathic pain by inhibiting microglial MAPK\/p-p38\/IL-1beta pathway activation","volume":"15","author":"Zheng","year":"2019","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2021.108835_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pain.2004.12.022","article-title":"ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model","volume":"114","author":"Zhuang","year":"2005","journal-title":"Pain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821003907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821003907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:13:42Z","timestamp":1758438822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821003907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":51,"alternative-id":["S0028390821003907"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108835","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed inhibition of ERK and p38 attenuates neuropathic pain without affecting motor function recovery after peripheral nerve injury","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108835"}}